Evidence map›Paper›PMID 41665525›Full record

ArticleMedical physics2026

Automated laser retraction for targeted glioblastoma coverage during laser interstitial thermal therapy.

Shreeniket Pawar, Yash Sharad Lad, Nageshwar Arepally, Ma'Moun Abu-Ayyad, Robert Ivkov, Brad E Zacharia, Constantinos Hadjipanayis, Anilchandra Attaluri

Abstract read
In one paragraph

Article in Medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Design, verification and validation of a spatially confined magnetic nanoparticle thermal therapy device for conformal thermal dose contouring.International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shreeniket PawarDepartment of Mechanical Engineering, School of Science, Engineering, and Technology, The Pennsylvania State University-Harrisburg, Middletown, Pennsylvania, USA.
Yash Sharad LadDepartment of Mechanical Engineering, School of Science, Engineering, and Technology, The Pennsylvania State University-Harrisburg, Middletown, Pennsylvania, USA.
Nageshwar ArepallyDepartment of Mechanical Engineering, School of Science, Engineering, and Technology, The Pennsylvania State University-Harrisburg, Middletown, Pennsylvania, USA.
Ma'Moun Abu-AyyadDepartment of Mechanical Engineering, School of Science, Engineering, and Technology, The Pennsylvania State University-Harrisburg, Middletown, Pennsylvania, USA.
Robert IvkovDepartment of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Brad E ZachariaDepartment of Neurosurgery, Pennsylvania State Health, Hershey, Pennsylvania, USA.
Constantinos HadjipanayisDepartment of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Anilchandra AttaluriDepartment of Mechanical Engineering, School of Science, Engineering, and Technology, The Pennsylvania State University-Harrisburg, Middletown, Pennsylvania, USA.

Funding

Translational Application of Magnetic Hyperthermia Therapy with Adjuvant Therapies for GlioblastomaR01CA247290 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HADJIPANAYIS, CONSTANTINOS GEORGE, IVKOV, ROBERT · 2020 to 2024
$3.5M
Precision magnetic hyperthermia by integrating magnetic particle imagingR01CA257557 · NCI · JOHNS HOPKINS UNIVERSITY · PI BULTE, JEFF W., IVKOV, ROBERT · 2021 to 2025
$3.2M
National Cancer Institute of the National Institute of Health CA257557NCI NIH HHS R01 CA247290NCI NIH HHS R01 CA257557
6 · The paper itself

Abstract

backgroundCurrent magnetic resonance guided laser interstitial thermal therapy (MRgLITT) requires physician input to incrementally retract the laser probe during glioblastoma (GBM) treatment, to achieve maximum safe lesion coverage (LC).

objectiveThrough this computational study, we propose an automated MRgLITT system based on temperature and thermal damage feedback to enable precise laser probe positioning and achieve the target LC during GBM treatment.

methodsOur goal was to design a cascaded proportional-integral-derivative (PID) controller with a fuzzy logic controller to achieve thermal damage, Ω ≥ 0.99 within 90% of the target tumor volume. Two modelling approaches were explored for PID control system to maintain the tumor boundary temperature at: (i) constant optical properties and (ii) variable optical properties. A fuzzy-logic controller was used to incrementally retract the laser probe once the thermal damage at the corresponding boundary setpoint reached the target (Ω = 0.99). The PID and fuzzy logic controller was designed in the system dynamic modeling software, MATLAB Simulink, and bioheat transfer physics was modelled using the finite element analysis (FEA) software, COMSOL Multiphysics. FEA simulations were performed on a de-identified patient voxel model consisting of domains such as the skull, CSF, brain and tumor. The laser probe was modeled as a cylinder with a diameter of 1.65 mm and tip length of 5 mm. The temperature and thermal damage measuring probes were modeled to represent the thermal imaging planes from clinically approved LITT systems.

resultsThe results indicated that the automated control framework maintained the tumor boundary temperature at 60°C. The designed automated control framework did not achieve the target LC but increased the LC by ∼25% with reduction in treatment time.

conclusionThe results of this computational study indicate that the designed automated MRgLITT approach has potential to improve the LC, reduce treatment time and operator specific variability. Future efforts will focus on developing and validating the proposed approach.

Indexed as

Brain NeoplasmsGlioblastomaHyperthermia, InducedLasersLaser TherapyAutomationFinite Element AnalysisFuzzy LogicHumansMagnetic Resonance ImagingTemperaturefuzzy logicGBMMRgLITTPIDprobe retraction

Identifiers

PMID41665525
PMCPMC12888946

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.